Clinical Information
patient
|
XJ206748 |
Age
|
61 |
Gender
|
M |
Genotype
|
HBV_gtC |
Diagnosis
|
hepatocellular carcinoma |
HBV DNA
|
6900IU/ml |
HBeAg
|
1 |
AFP(ng/ml)
|
442.5 |
PLT(log IU/mL)
|
181 |
HBcAb
|
1 |
HBsAb
|
1 |
HBeAb
|
1 |
HBsAg
|
1 |
ctDNA concentration
|
0.06143 |
marker
|
ctDNA- |
Hospital
|
Eastern Hepatobiliary Surgery Hospital, Shanghai |
HBsAg (IU/ml)
|
15.74 |
BCLC
|
C |
ACJJ
|
IIIA |
Tumor maximum size
|
10 |
Tumor count
|
2 |
MVI
|
M2 |
AFP-L3
|
14.3 |
PIVKA-II (mAU/ml)
|
9454 |
CA199 (U/ml)
|
38.8 |
Cirrhosis history
|
1 |
Fatty liver
|
0 |
Hepatic encephalopathy (1-3)
|
1 |
Ascites (1-3)
|
1 |
TBIL (μmol/L)
|
1 |
ALB (g/L)
|
2 |
INR
|
1 |
Score
|
6 |
Child-Pugh stage
|
A |
HBV integration detection
|
Yes |
Integration number
|
53 |
HBV subtype frequency
|
0.989037759 |
|
|